These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34678045)

  • 1. IL-12 regulates type 3 immunity through interfollicular keratinocytes in psoriasiform inflammation.
    Zwicky P; Ingelfinger F; Silva de Melo BM; Ruchti F; Schärli S; Puertas N; Lutz M; Phan TS; Kündig TM; Levesque MP; Maul JT; Schlapbach C; LeibundGut-Landmann S; Mundt S; Becher B
    Sci Immunol; 2021 Oct; 6(64):eabg9012. PubMed ID: 34678045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.
    Xu M; Lu H; Lee YH; Wu Y; Liu K; Shi Y; An H; Zhang J; Wang X; Lai Y; Dong C
    Immunity; 2018 Apr; 48(4):787-798.e4. PubMed ID: 29653697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-IL-12/IL-23p40 antibody ameliorates dermatitis and skin barrier dysfunction in mice with imiquimod-induced psoriasis-like dermatitis.
    Takahashi T; Koga Y; Kainoh M
    Eur J Pharmacol; 2018 Jun; 828():26-30. PubMed ID: 29544684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 protects from psoriasiform skin inflammation.
    Kulig P; Musiol S; Freiberger SN; Schreiner B; Gyülveszi G; Russo G; Pantelyushin S; Kishihara K; Alessandrini F; Kündig T; Sallusto F; Hofbauer GF; Haak S; Becher B
    Nat Commun; 2016 Nov; 7():13466. PubMed ID: 27892456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic Abnormalities of Keratinocytes Initiate Skin Inflammation through the IL-23/T17 Axis in a MALT1-Dependent Manner.
    Zhang S; Wang M; Wang C; Wang G; Sun K; Xiong S; Cheng L; Yang D; Lin X; Zhao X
    J Immunol; 2021 Feb; 206(4):839-848. PubMed ID: 33419765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A9 Drives the Chronification of Psoriasiform Inflammation by Inducing IL-23/Type 3 Immunity.
    Silva de Melo BM; Veras FP; Zwicky P; Lima D; Ingelfinger F; Martins TV; da Silva Prado D; Schärli S; Publio G; Hiroki CH; Melo PH; Saraiva A; Norbiato T; Lima L; Ryffel B; Vogl T; Roth J; Waisman A; Nakaya HI; da Silva Souza C; Cunha FQ; Cunha TM; Becher B; Alves-Filho JC
    J Invest Dermatol; 2023 Sep; 143(9):1678-1688.e8. PubMed ID: 36921684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte-intrinsic BCL10/MALT1 activity initiates and amplifies psoriasiform skin inflammation.
    Kurgyis Z; Vornholz L; Pechloff K; Kemény LV; Wartewig T; Muschaweckh A; Joshi A; Kranen K; Hartjes L; Möckel S; Steiger K; Hameister E; Volz T; Mellett M; French LE; Biedermann T; Korn T; Ruland J
    Sci Immunol; 2021 Nov; 6(65):eabi4425. PubMed ID: 34826258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
    Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
    J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
    Srivastava A; Nikamo P; Lohcharoenkal W; Li D; Meisgen F; Xu Landén N; Ståhle M; Pivarcsi A; Sonkoly E
    J Allergy Clin Immunol; 2017 Feb; 139(2):550-561. PubMed ID: 27568078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation.
    Wang Z; Zhou H; Zheng H; Zhou X; Shen G; Teng X; Liu X; Zhang J; Wei X; Hu Z; Zeng F; Hu Y; Hu J; Wang X; Chen S; Cheng J; Zhang C; Gui Y; Zou S; Hao Y; Zhao Q; Wu W; Zhou Y; Cui K; Huang N; Wei Y; Li W; Li J
    Autophagy; 2021 Feb; 17(2):529-552. PubMed ID: 32019420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitis.
    Goldstein JD; Bassoy EY; Caruso A; Palomo J; Rodriguez E; Lemeille S; Gabay C
    Life Sci Alliance; 2020 Jun; 3(6):. PubMed ID: 32345660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapy.
    Gupta RK; Gracias DT; Figueroa DS; Miki H; Miller J; Fung K; Ay F; Burkly L; Croft M
    Sci Immunol; 2021 Nov; 6(65):eabi8823. PubMed ID: 34797693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis.
    Chen HL; Lo CH; Huang CC; Lu MP; Hu PY; Chen CS; Chueh DY; Chen P; Lin TN; Lo YH; Hsiao YP; Hsu DK; Liu FT
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33055419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk.
    Tortola L; Rosenwald E; Abel B; Blumberg H; Schäfer M; Coyle AJ; Renauld JC; Werner S; Kisielow J; Kopf M
    J Clin Invest; 2012 Nov; 122(11):3965-76. PubMed ID: 23064362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating-factor-induced psoriasiform dermatitis resembles psoriasis with regard to abnormal cytokine expression and epidermal activation.
    Mössner R; Beckmann I; Hallermann C; Neumann C; Reich K
    Exp Dermatol; 2004 Jun; 13(6):340-6. PubMed ID: 15186319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-12, interleukin-23, and psoriasis: current prospects.
    Torti DC; Feldman SR
    J Am Acad Dermatol; 2007 Dec; 57(6):1059-68. PubMed ID: 17706835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
    Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
    Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyk2 is a therapeutic target for psoriasis-like skin inflammation.
    Ishizaki M; Muromoto R; Akimoto T; Sekine Y; Kon S; Diwan M; Maeda H; Togi S; Shimoda K; Oritani K; Matsuda T
    Int Immunol; 2014 May; 26(5):257-67. PubMed ID: 24345760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratinocyte interleukin-36 receptor expression orchestrates psoriasiform inflammation in mice.
    Hernández-Santana YE; Leon G; St Leger D; Fallon PG; Walsh PT
    Life Sci Alliance; 2020 Apr; 3(4):. PubMed ID: 32086318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.